The Use of Nimesulide and Its Analogues in Cancer Chemoprevention

ISSN: 1875-5992 (Online)
ISSN: 1871-5206 (Print)

Volume 16, 12 Issues, 2016

Download PDF Flyer

Anti-Cancer Agents in Medicinal Chemistry

Formerly: Current Medicinal Chemistry - Anti-Cancer Agents

Aims & ScopeAbstracted/Indexed in

Ranking and Category:
  • 27th of 59 in Chemistry, Medicinal

Submit Abstracts Online Submit Manuscripts Online

Michelle Prudhomme
Universite Blaise Pascal - C.N.R.S
Aubiere Cedex

View Full Editorial Board

Subscribe Purchase Articles Order Reprints

Current: 2.722
5 - Year: 2.849

The Use of Nimesulide and Its Analogues in Cancer Chemoprevention

Anti-Cancer Agents in Medicinal Chemistry, 6(3): 233-237.

Author(s): Jean-Francois Renard, Fabien Julemont, Xavier d. Leval and Bernard Pirotte.

Affiliation: Laboratoire de Chimiepharmaceutique, Natural and Synthetic Drugs Research Center, Universitede Liege, 1, Avenue de l'Hopital, Sart Tilman, B-4000 Liege, Belgium.


Non-steroidal anti-inflammatory drugs (NSAIDs), which are known to be cyclooxygenase (COX) inhibitors, have been reported to exert anti-proliferative and pro-apoptotic effects on a variety of cancer cells. Since the COX-2 isoform was found to be overexpressed in a many human cancers, a particular attention was paid on the possible use of selective COX-2 inhibitors in cancer chemoprevention. The present review focuses on the state of the art in cancer research developed with COX-2 preferential/selective inhibitors belonging to the family of N-arylmethanesulfonamides, in particular nimesulide and NS-398.


Nimesulide, NS-398, cancer chemoprevention, NSAIDs, cyclooxygenase inhibitors, anti-proliferative, proapoptotic, N-arylmethanesulfonamides.

Purchase Online Order Reprints Order Eprints Rights and Permissions

Article Details

Volume: 6
Issue Number: 3
First Page: 233
Last Page: 237
Page Count: 5
DOI: 10.2174/187152006776930855
Price: $58

Related Journals

Webmaster Contact: Copyright © 2016 Bentham Science